HomeWorld NewsChina Gives Conditional Approval for Pfizer's COVID Drug Paxlovid

China Gives Conditional Approval for Pfizer’s COVID Drug Paxlovid

BEIJING (Reuters) – China’s medical products regulator said on Saturday it has given conditional approval for Pfizer’s COVID-19 medicine Paxlovid to treat adults with mild to moderate disease who have high risk of progressing to a severe condition.

The National Medical Products Administration said further study on the drug needed to be conducted and submitted to the authority.

(Writing by William Mallard)

Copyright 2022 Thomson Reuters,


- Advertisment -

Most Popular

Recent Comments